Prestige Consumer Healthcare PBH
$ 78.58
-0.1%
Quarterly report 2024-Q3
added 11-07-2024
Prestige Consumer Healthcare Balance Sheet 2011-2024 | PBH
Annual Balance Sheet Prestige Consumer Healthcare
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.08 B | 1.29 B | 1.46 B | 1.45 B | 1.67 B | 1.77 B | 1.96 B | 2.15 B | 1.6 B | 1.57 B | 906 M | 955 M | 1.1 B | 474 M |
Long Term Debt |
1.13 B | 1.35 B | 1.48 B | 1.48 B | 1.73 B | 1.8 B | 1.99 B | 2.19 B | 1.63 B | 1.59 B | 934 M | 971 M | 1.12 B | 487 M |
Long Term Debt Current |
4.66 M | 6.93 M | 6.36 M | 5.86 M | 5.61 M | 5.7 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 2.19 B | 2.22 B | 2.46 B | 2.93 B | 2.1 B | 1.94 B | 1.15 B | 1.17 B | 1.29 B | 641 M |
Total Current Liabilities |
117 M | 161 M | 143 M | 122 M | 150 M | 127 M | 123 M | 162 M | 107 M | 99 M | 84.4 M | 96.7 M | 63.9 M | - |
Total Liabilities |
1.66 B | 1.91 B | 2.09 B | 2.07 B | 2.34 B | 2.35 B | 2.58 B | 3.09 B | 2.2 B | 2.04 B | 1.23 B | 1.26 B | 1.36 B | 695 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.34 B | 1.13 B | 1.21 B | 1.01 B | 844 M | 702 M | 736 M | 397 M | 327 M | 227 M | 149 M | 76.2 M | 10.7 M | -26.2 M |
Total Assets |
3.32 B | 3.35 B | 3.67 B | 3.43 B | 3.51 B | 3.44 B | 3.76 B | 3.91 B | 2.95 B | 2.67 B | 1.8 B | 1.74 B | 1.76 B | 1.06 B |
Cash and Cash Equivalents |
46.5 M | 58.5 M | 27.2 M | 32.3 M | 94.8 M | 27.5 M | 32.5 M | 41.9 M | 27.2 M | 21.3 M | 28.3 M | 15.7 M | 19 M | 13.3 M |
Book Value |
1.66 B | 1.45 B | 1.58 B | 1.36 B | 1.17 B | 1.1 B | 1.18 B | 823 M | 744 M | 628 M | 563 M | 478 M | 403 M | 362 M |
Total Shareholders Equity |
1.66 B | 1.45 B | 1.58 B | 1.36 B | 1.17 B | 1.1 B | 1.18 B | 823 M | 744 M | 628 M | 563 M | 478 M | 403 M | 362 M |
All numbers in USD currency
Quarterly Balance Sheet Prestige Consumer Healthcare
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.06 B | 1.1 B | 1.21 B | 1.28 B | 1.33 B | 1.36 B | 1.44 B | 1.46 B | - | 1.5 B | 1.55 B | 1.61 B | 1.55 B | 1.48 B | 1.55 B | 1.55 B | 1.62 B | 1.73 B | 1.7 B | 1.75 B | 1.78 B | 1.8 B | 1.84 B | 1.9 B | 1.99 B | 1.99 B | 2.05 B | 2.09 B | 2.15 B | 2.19 B | 1.42 B | 1.48 B | 1.58 B | 1.63 B | 1.45 B | 1.47 B | 1.51 B | 1.56 B | 1.64 B | 1.69 B | 970 M | 934 M | 982 M | 979 M | 953 M | 971 M | 1 B | 1.08 B | 1.1 B | 1.12 B | 430 M | 447 M | 464 M | 487 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 358 K | - | 302 K | 296 K | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.59 B | 1.63 B | 1.74 B | 1.8 B | 1.87 B | 1.91 B | 2.06 B | 2.06 B | - | 2.09 B | 2.14 B | 2.21 B | 2.14 B | 2.07 B | 2.15 B | 2.16 B | 2.22 B | 2.34 B | 2.31 B | 2.35 B | 2.36 B | 2.35 B | 2.43 B | 2.5 B | 2.61 B | 2.58 B | 2.68 B | 3.01 B | 3.04 B | 3.09 B | 2.01 B | 2.06 B | 2.14 B | 2.2 B | 1.92 B | 1.94 B | 1.97 B | 2.01 B | 2.07 B | 2.13 B | 1.27 B | 1.23 B | 1.32 B | 1.27 B | 1.24 B | 1.26 B | 1.27 B | 1.35 B | 1.33 B | 1.36 B | 644 M | 664 M | 671 M | 695 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.44 B | 1.39 B | 1.29 B | 1.24 B | 1.19 B | 1.13 B | 1.37 B | 1.32 B | - | 1.21 B | 1.16 B | 1.11 B | 1.07 B | 1.01 B | 973 M | 932 M | 888 M | 844 M | 807 M | 769 M | 736 M | 702 M | 841 M | 803 M | 772 M | 736 M | 776 M | 461 M | 430 M | 397 M | 386 M | 354 M | 322 M | 327 M | 313 M | 285 M | 254 M | 227 M | 204 M | 182 M | 166 M | 149 M | 133 M | 130 M | 96.9 M | 76.2 M | 56.9 M | 44.6 M | 25.4 M | 10.7 M | 11 M | 1.53 M | -11.4 M | -26.2 M |
Total Assets |
3.32 B | 3.31 B | 3.34 B | 3.33 B | 3.35 B | 3.35 B | 3.75 B | 3.68 B | - | 3.67 B | 3.66 B | 3.68 B | 3.56 B | 3.43 B | 3.47 B | 3.43 B | 3.45 B | 3.51 B | 3.46 B | 3.46 B | 3.46 B | 3.44 B | 3.67 B | 3.7 B | 3.77 B | 3.76 B | 3.9 B | 3.9 B | 3.9 B | 3.91 B | 2.81 B | 2.83 B | 2.88 B | 2.95 B | 2.64 B | 2.63 B | 2.64 B | 2.64 B | 2.68 B | 2.73 B | 1.85 B | 1.8 B | 1.86 B | 1.81 B | 1.74 B | 1.74 B | 1.73 B | 1.79 B | 1.75 B | 1.76 B | 1.05 B | 1.06 B | 1.05 B | 1.06 B |
Cash and Cash Equivalents |
51.5 M | 34.3 M | 63.6 M | 60.1 M | 54.6 M | 58.5 M | 86.4 M | 42.4 M | 35.9 M | 27.2 M | 21 M | 42.8 M | 164 M | 32.3 M | 62.1 M | 26.6 M | 57.9 M | 94.8 M | 28.6 M | 27.9 M | 29 M | 27.5 M | 24.7 M | 36.9 M | 34.3 M | 32.5 M | 45.4 M | 43 M | 44.1 M | 41.9 M | 63.3 M | 30.5 M | 28.9 M | 27.2 M | 49 M | 22.2 M | 21.6 M | 21.3 M | 22 M | 21.7 M | 15.7 M | 28.3 M | 94.4 M | 26.8 M | 19.3 M | 15.7 M | 10.4 M | 29 M | 4.4 M | 19 M | 4.44 M | 7.96 M | 5.99 M | 13.3 M |
Book Value |
1.73 B | 1.68 B | 1.6 B | 1.54 B | 1.48 B | 1.45 B | 1.69 B | 1.62 B | - | 1.58 B | 1.52 B | 1.46 B | 1.42 B | 1.36 B | 1.32 B | 1.28 B | 1.23 B | 1.17 B | 1.16 B | 1.11 B | 1.1 B | 1.1 B | 1.23 B | 1.19 B | 1.16 B | 1.18 B | 1.22 B | 896 M | 859 M | 823 M | 800 M | 775 M | 737 M | 744 M | 721 M | 686 M | 663 M | 628 M | 609 M | 594 M | 586 M | 563 M | 544 M | 541 M | 500 M | 478 M | 457 M | 439 M | 418 M | 403 M | 402 M | 391 M | 378 M | 362 M |
Total Shareholders Equity |
1.73 B | 1.68 B | 1.6 B | 1.54 B | 1.48 B | 1.45 B | 1.69 B | 1.62 B | 1.58 B | 1.58 B | 1.52 B | 1.46 B | 1.42 B | 1.42 B | 1.32 B | 1.32 B | 1.28 B | 1.17 B | 1.16 B | 1.16 B | 1.11 B | 1.1 B | 1.23 B | 1.23 B | 1.19 B | 1.18 B | 1.22 B | 896 M | 859 M | 823 M | 800 M | 775 M | 737 M | 744 M | 721 M | 686 M | 663 M | 628 M | 609 M | 594 M | 586 M | 563 M | 544 M | 541 M | 500 M | 478 M | 457 M | 439 M | 418 M | 403 M | 402 M | 391 M | 378 M | 362 M |
All numbers in USD currency